Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Pharmacology and Experimental Therapeutics|May 25, 2025
Death receptor 5 agonists mitigate cardiac pathology in a chronic isoproterenol-induced cardiac remodeling and dysfunctionMiles A Tanner, Katrina Dougherty, Laurel A Grisanti
American Journal of Physiology. Heart and Circulatory Physiology|August 20, 2021
Immune cell β2-adrenergic receptors contribute to the development of heart failureMiles A Tanner, Charles A Maitz, Laurel A Grisanti
JACC. Basic to Translational Science|September 4, 2018
Designer Approaches for G Protein-Coupled Receptor Modulation for Cardiovascular DiseaseLaurel A Grisanti, Sarah M Schumacher, Douglas G Tilley, et al.
European Journal of Pharmacology|June 12, 2012
Phospholipase C not protein kinase C is required for the activation of TRPC5 channels by cholecystokininLaurel A Grisanti, Lalitha Kurada, Nicholas I Cilz, et al.
Cellular Signalling|July 17, 2017
Impact of paroxetine on proximal β-adrenergic receptor signalingShuchi Guo, Rhonda L Carter, Laurel A Grisanti, et al.
JCI Insight|March 29, 2019
Prior β-blocker treatment decreases leukocyte responsiveness to injuryLaurel A Grisanti, Claudio de Lucia, Toby P Thomas, et al.
Cellular Signalling|March 30, 2021
Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: The RECKlessness of adverse remodelingJacob J Russell, Laurel A Grisanti, Scott M Brown, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 17, 2011
α1-adrenergic receptors positively regulate Toll-like receptor cytokine production from human monocytes and macrophagesLaurel A Grisanti, Andrew P Woster, Julie Dahlman, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
β2-Adrenergic receptor-dependent chemokine receptor 2 expression regulates leukocyte recruitment to the heart following acute injuryLaurel A Grisanti, Christopher J Traynham, Ashley A Repas, et al.
Plos One|June 6, 2014
β-adrenergic receptor-dependent alterations in murine cardiac transcript expression are differentially regulated by gefitinib in vivoJennifer A Talarico, Rhonda L Carter, Laurel A Grisanti, et al.
Pageof 5